This invention provides a weight-loss formulation for subjects, wherein the
active ingredient of the weight-loss formulation is
carrageenan. This invention also provides the application of the
active ingredient composed of
carrageenan in the preparation of the weight-loss formulation for subjects. This invention creatively uses
carrageenan alone as an
active ingredient for
weight loss, achieving very good weight-loss effects. At 24h, 48h, 72h, and 96h after injection,
body weight decreased by 9.97% (P<0.05), 10.24% (P<0.05), 11.19% (P<0.01), and 13.21% (P<0.01), respectively, showing a gradually increasing trend,
rapid onset, and significant effect. The weight-loss effect is superior to the latest oral weight-loss
drug, the small-molecule GLP-1R
agonist orforglipron. Furthermore, carrageenan, as an active ingredient, can also suppress
appetite, reduce
defecation, and increase
urination.